Azamulin is a pleuromutilin antibiotic.

[1] As of 2021[update], it is not marketed in the US or Europe.

[citation needed] In pharmacological studies, the substance is used as an inhibitor of the liver enzymes CYP3A4 and CYP3A5.

[2][3] This systemic antibiotic-related article is a stub.

You can help Wikipedia by expanding it.